Role of metformin in radiotherapy and chemotherapy

There are several published reports showing antidiabetic agent metformin prevents the development of cancer and has an important role in the treatment of cancer. According to the recent studies, metformin is reported to enhance the effect of chemotherapy and radiotherapy, especially in cancer related to diabetes. But it is difficult to analyze the initiation of treatment as it has been recently started to be investigated. There is a need for prospective studies to investigate the efficacy and / or safety of metformin in combination with radiotherapy and chemotherapy in cancer treatment and in cancer patients.

___

Ki YJ, Kim HJ, Kim MS, et al. Association between Metformin Use and Survival in Nonmetastatic Rectal Cancer Treated with a Curative Resection: A Nationwide Population Study. Cancer Res Treat. 2016 Jul 4 [Epub ahead of print]

Koritzinsky M. Metformin: A Novel Biological Modifier of Tumor Response to Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015;93:454-64.

Jiralerspong S, Palla SL, Giordano SH, et al. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol. 2009;27:3297–302.

Ji-Won Jung, Sang-Bum Park, Soo-Jin Lee, et al. Trosko, Kyung-Sun Kang. Metformin Represses Self-Renewal of the Human Breast Carcinoma Stem Cells via Inhibition of Estrogen Receptor-Mediated OCT4 Expression. PLoS ONE, 2011;6:e28068

Alimova IN, Liu B, Fan Z, et al. Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell cycle. 2009;8:909–15.

Sanli T, Rashid A, Liu C, Harding S, et al. Ionizing radiation activates AMPactivated kinase (AMPK): a target for radiosensitization of human cancer cells. Int J Radiat Oncol Biol Phys. 2010;78:221-9.

Wang J, Xia S, Zhu Z. Synergistic effect of phenformin in non-small cell lung cancer (NSCLC) ionizing radiation treatment. Cell Biochem Biophys. 201571:513-8.

Shell SA, Lyass L, Trusk PB, et al. Activation of AMPK is necessary for killing cancer cells and sparing cardiac cells. Cell Cycle. 2008;7:1769–75.
Medicine Science-Cover
  • ISSN: 2147-0634
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2012
  • Yayıncı: Effect Publishing Agency ( EPA )
Sayıdaki Diğer Makaleler

Synthesis and the effect of a novel benzoxazole compound on breast cancer cell line

FUNDA KOSOVA, Özlem TEMİZ ARPACI, ERCÜMENT ÖLMEZ, MEHMET İBRAHİM TUĞLU

Can bevacizumab administered together with beta radiation in treatment of pterygium play a role in additive effect and/or treatment of the side effects?

Yasemin BENDERLİ CİHAN, Fatma BAĞCI

Determination of fibromyalgia syndrome in patients with non-cardiac chest pain in accordance with 1990 and 2010 diagnostic criteria

Arif GÜLKESEN

Terra firma-forme dermatosis: Two cases

Dursun TURKMEN

Smoking patterns and cessation counseling practices among physicians in Turkey

Çiğdem TEKİN, GÜLSEN GÜNEŞ, Erkay NACAR, Burak METE, Ertan UNVER

Accurate diagnostic algorithm for patients with rare pathology of thenar intramuscular lipomas

Zafer ATBAŞI, YUSUF ERDEM

Assessment of vitamin D level in Hashimoto thyroiditis in Turkish population

Banu Şarer YÜREKLİ, Ezgi BELLİKÇİ KOYU, Hatice ÖZIŞIK, Dilek ONGAN, Gökhan ÖZGEN

The effects of different centrifugation temperatures on blood coagulation parameters

Esin ÇALCI, ÇİĞDEM YÜCEL, Turan TURHAN

Fascia iliaca block for postoperative analgesia in a hip fracture patient

Onur BARAN, Ayhan ŞAHİN, Bünyamin KIR, Irem ATES

Evaluation of impulsivity and complex attention functions of subjects with substance use: Sample from Adiyaman province

Ali KUŞTEPE, Aysun KALENDEROĞLU, Mustafa ÇELİK, Esra KAYA BOZKURT, Mehmet Hamdi ÖRÜM, Şükrü UĞUZ